Access to specialized kidney care varies by geographic area and race
2014-11-15
(Press-News.org) Philadelphia, PA (November 15, 2014) -- Patients' access to specialized care before kidney failure develops varies significantly across the United States and among different racial groups, according to studies that will be presented at ASN Kidney Week 2014 November 11¬-16 at the Pennsylvania Convention Center in Philadelphia, PA.
For patients who develop kidney failure, or end-stage renal disease (ESRD), the kidney care they received while their kidneys were still functioning is critically important. Using a comprehensive national dataset and advanced statistical modeling techniques, Brendan Lovasik (Emory University School of Medicine) and his colleagues identified several geographic areas in the United States with significantly low rates of pre-ESRD kidney care. The areas included San Francisco, Los Angeles, Chicago, Miami, Baltimore, and along the corridors of the Mississippi and Ohio Rivers. Facilities in areas with the lowest rate of pre-ESRD kidney care were more likely to be located in inner cities and in high-poverty neighborhoods. The proportion of racial minorities within a neighborhood was not associated with pre-ESRD kidney care rates.
"Improved outcomes among the chronic kidney disease population depend on earlier identification of patients with kidney disease who may require ESRD treatment, as well as greater awareness of patient morbidity and mortality, quality of life, and the financial benefits of kidney transplantation over dialysis," said Lovasik. "Our findings may help policy makers target low-pre-ESRD facilities and regions to improve access to specialty care with interventions and specific pilot programs aimed at improving patient outcomes."
In another study, Guofen Yan, PhD (University of Virginia) and her team found that while disparities in pre-ESRD care were more likely in certain geographic areas, they existed in diverse locations and in most US counties. The overall percentage of patients who received care from a kidney specialist at least 12 months before ESRD was lowest in Hispanics (20.0%), intermediate in blacks (23.8%), and highest in whites (30.0%). In an analysis of 1270 counties, black patients' odds of receiving care from a kidney specialist were 10% to 54% lower than that of whites in approximately two-thirds of the counties. Among 613 counties, Hispanics' odds of receiving nephrologist care were 10% to 48% lower than that of whites in nearly all of the counties. "Our findings indicate that efforts to improve pre-ESRD care should be implemented nationally rather than regionally," said Dr. Yan.
INFORMATION:
Studies:
"Geographic Determinants of Low Pre-ESRD Nephrology Care in the United States" (Abstract SA-PO849)
"Racial and Ethnic Differences in Pre-ESRD Care in U.S. Counties" (Abstract SA-PO857)
Disclosure information is available at
http://www.asn-online.org/education/kidneyweek/2014/program-faculty.aspx.
ASN Kidney Week 2014, the largest nephrology meeting of its kind, will provide a forum for more than 13,000 professionals to discuss the latest findings in renal research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. Kidney Week 2014 will take place November 11-16, 2014 in Philadelphia, PA.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, and with more than 15,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.
ELSE PRESS RELEASES FROM THIS DATE:
2014-11-15
Philadelphia, PA - November 15, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced results from a 48-week Open Label Extension (OLE) safety study in which Ferric Citrate demonstrated long-term safety and efficacy in dialysis-dependent chronic kidney disease (CKD) patients with elevated serum phosphorus levels, or hyperphosphatemia. The OLE findings were presented as a late-breaking poster (Abstract #SA-PO1102) at the 2014 American Society of Nephrology's (ASN) Kidney Week meeting in Philadelphia, PA. The results are consistent with those ...
2014-11-15
Philadelphia, PA (November 15, 2014) -- Potassium additives are frequently added to sodium-reduced meat products in amounts that may be dangerous for patients with kidney disease, according to a study that will be presented at ASN Kidney Week 2014 November 11¬-16 at the Pennsylvania Convention Center in Philadelphia, PA.
Sodium-reduced foods are becoming increasingly available to consumers; however food manufacturers may use phosphate and potassium additives to replace the functional and flavor properties of sodium. Because individuals with kidney dysfunction must ...
2014-11-15
Philadelphia, PA (November 15, 2014) -- Air pollution may play a role in the development of kidney disease, according to a study that will be presented at ASN Kidney Week 2014 November 11¬-16 at the Pennsylvania Convention Center in Philadelphia, PA.
There are wide variances in the prevalence of chronic kidney disease (CKD) across the United States, only part of which is explained by differences in individuals' risk factors. To see if air quality may also play a role, Jennifer Bragg-Gresham, PhD (University of Michigan) and her colleagues looked at 2010 Medicare information ...
2014-11-15
Philadelphia, PA (November 15, 2014) -- Home dialysis therapies may help prolong the lives of patients with kidney failure compared with hemodialysis treatments administered in medical centers, according to a study that will be presented at ASN Kidney Week 2014 November 11¬-16 at the Pennsylvania Convention Center in Philadelphia, PA.
Home dialysis therapies are more convenient and less expensive than in-center treatment, but it's unclear whether all home therapies--which include peritoneal dialysis and home hemodialysis--can prolong patients' survival. Researchers ...
2014-11-15
Abstract 16039/Presentation 1 (Lakeside Hall D1, Cross Core)
American Heart Association pre-arrival telephone CPR guidelines help save lives
Implementing American Heart Association pre-arrival telephone CPR guidelines throughout Arizona has dramatically increased the number of bystanders performing CPR and survival from cardiac arrest, according to research presented at the American Heart Association's Scientific Sessions 2014.
The guidelines call for emergency dispatchers and call takers to provide assertive step-by-step Telephone-CPR instructions to bystanders during ...
2014-11-15
Philadelphia, PA (November 15, 2014) -- The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2014, November 11-16 at the Pennsylvania Convention Center in Philadelphia, PA.
Among the studies are the following (presented in numerical order):
SA-PO1092 A Randomized Multicomponent Intervention to Reduce Disparities in Transplant Referral: Interim Results from the RaDIANT Community Study -- Rachel E. Patzer, Leighann Sauls, Jennifer C. Gander, M. Ahinee Amamoo, Laura Plantinga, Debra D. Evans, ...
2014-11-15
Philadelphia, PA (November 15, 2014) -- The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2014, November 11-16 at the Pennsylvania Convention Center in Philadelphia, PA.
A trial of 156 patients who developed acute kidney injury (AKI) following cardiac surgery found that treatment with certain stem cells did not shorten the time it took patients to achieve complete kidney recovery, nor did it decrease their risk of dying prematurely or needing dialysis. Unfortunately, "AKI is common condition ...
2014-11-15
Using two drugs was no more effective than a single drug in slowing disease progression in people with autosomal dominant polycystic kidney disease (ADPKD), according to two studies funded by the National Institutes of Health (NIH). One of the studies also showed that rigorous blood pressure treatment slowed growth of kidney cysts, a marker of ADPKD, but had little effect on kidney function compared to standard blood pressure treatment.
The results of the HALT-PKD Clinical Trials Network studies will be published online November 15 in two papers in the New England Journal ...
2014-11-15
In patients undergoing noncardiac surgery, neither aspirin nor clonidine (a medication primarily used to treat high blood pressure) taken before and after surgery reduced the risk of acute kidney injury, according to a study appearing in JAMA. The study is being released to coincide with its presentation at the American Society of Nephrology's annual Kidney Week meeting.
About 10 percent of the 200 million adults estimated to undergo major noncardiac surgery each year develop acute kidney injury (a sudden loss of kidney function). Perioperative (around the time of surgery) ...
2014-11-15
Among kidney transplant recipients, a 3-month course of the antibiotic levofloxacin following transplantation did not prevent the major complication known as BK virus from appearing in the urine. The intervention was associated with an increased risk of adverse events such as bacterial resistance, according to a study appearing in JAMA. The study is being released to coincide with its presentation at the American Society of Nephrology's annual Kidney Week meeting.
Kidney transplantation is the preferred treatment for endstage renal disease. The development of potent ...
LAST 30 PRESS RELEASES:
[Press-News.org] Access to specialized kidney care varies by geographic area and race